trending Market Intelligence /marketintelligence/en/news-insights/trending/oLUWd0jjoF2NlDEP_EI-Uw2 content esgSubNav
In This List

Novogen to change name, consolidate stocks

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


Novogen to change name, consolidate stocks

Novogen Ltd is seeking shareholder approval to change its name to Kazia Therapeutics Ltd. and to consolidate its shares.

Novogen intends to implement a 1-for-10 share consolidation to have a more appropriate capital structure as well as reduce administrative costs resulting from a large number of issued shares.

The share consolidation is expected to be effective Dec. 31.